A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan
Ana Ortega-Molina, Alejo Efeyan(Spanish National Cancer Research Centre), Nathan L. Price(National Institutes of Health), María Casanova-Acebes(Spanish National Cancer Research Centre), Consuelo Borrás(Universitat de València), Yurena Vivas(Spanish National Cancer Research Centre), Elena Fernández-Florido(Spanish National Cancer Research Centre), Alejandra Aroca-Crevillén(Spanish National Centre for Cardiovascular Research), Patricia González‐García(Spanish National Cancer Research Centre), Cristina Lebrero‐Fernández(Spanish National Cancer Research Centre), Miguel Calvo‐Rubio(University of Córdoba), Osvaldo Graña‐Castro(Spanish National Cancer Research Centre), Nerea Deleyto-Seldas(Spanish National Cancer Research Centre), Daniel Monleón(Universitat de València), Lucía de Prado-Rivas(Spanish National Cancer Research Centre), Elena García(Spanish National Cancer Research Centre), Eduardo Caleiras(Spanish National Cancer Research Centre), Alba Sanz(Spanish National Cancer Research Centre), Ana Belén Plata-Gómez(Spanish National Cancer Research Centre)
Cited by 40
Related Papers
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H <sup>+</sup> -ATPase
|Science|2011|1.6k
Senescence in premalignant tumours
|Nature|2005|1.5k